65 related articles for article (PubMed ID: 31970865)
1. Negative reactions of BRAF mutation-specific immunohistochemistry to non-V600E mutations of BRAF.
Seto K; Haneda M; Masago K; Fujita S; Kato S; Sasaki E; Hosoda W; Murakami Y; Kuroda H; Horio Y; Hida T; Okubo K; Yatabe Y
Pathol Int; 2020 May; 70(5):253-261. PubMed ID: 31970865
[TBL] [Abstract][Full Text] [Related]
2. A highly sensitive and specific real-time quantitative PCR for BRAF V600E/K mutation screening.
Lung J; Hung MS; Lin YC; Jiang YY; Fang YH; Lu MS; Hsieh CC; Wang CS; Kuan FC; Lu CH; Chen PT; Lin CM; Chou YL; Lin CK; Yang TM; Chen FF; Lin PY; Hsieh MJ; Tsai YH
Sci Rep; 2020 Oct; 10(1):16943. PubMed ID: 33037234
[TBL] [Abstract][Full Text] [Related]
3. Clinicogenomic Features and Targetable Mutations in NSCLCs Harboring BRAF Non-V600E Mutations: A Multi-Institutional Genomic Screening Study (LC-SCRUM-Asia).
Sakai T; Matsumoto S; Ueda Y; Shibata Y; Ikeda T; Nakamura A; Kodani M; Ohashi K; Furuya N; Izumi H; Nosaki K; Umemura S; Zenke Y; Udagawa H; Sugiyama E; Yoh K; Goto K
J Thorac Oncol; 2023 Nov; 18(11):1538-1549. PubMed ID: 37543207
[TBL] [Abstract][Full Text] [Related]
4. A patient with BRAF N581S mutation-positive lung adenocarcinoma demonstrates durable response to combined anlotinib and tislelizumab: A case report and literature review.
Liu Y; Li M; Guo Y; Zhang Z; Du L; Zhang X; Wang Y; Zhang D; Xue L; Lei B; Su J; Zhang R; Chen J; Zhang X; Jia Q; Tian C
Pathol Res Pract; 2024 Jul; 259():155371. PubMed ID: 38820929
[TBL] [Abstract][Full Text] [Related]
5. The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients.
Lin Q; Zhang H; Ding H; Qian J; Lizaso A; Lin J; Han-Zhang H; Xiang J; Li Y; Zhu H
J Transl Med; 2019 Aug; 17(1):298. PubMed ID: 31470866
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation.
Ambrosini-Spaltro A; Rengucci C; Capelli L; Chiadini E; Calistri D; Bennati C; Cravero P; Limarzi F; Nosseir S; Panzacchi R; Valli M; Ulivi P; Rossi G
Curr Oncol; 2023 Nov; 30(11):10019-10032. PubMed ID: 37999148
[TBL] [Abstract][Full Text] [Related]
7. Case report: Dual dabrafenib and trametinib therapy for treating BRAF V600E mutated lung adenocarcinoma with BRCA2 germline mutation post multiline progression.
Zhang H; Cong X; Yin J; Chen C; Liu Z
Front Oncol; 2024; 14():1387388. PubMed ID: 38715777
[TBL] [Abstract][Full Text] [Related]
8. Response to dabrafenib plus trametinib on a rare BRAF mutation (V600_W604 deletion-insertion R) in an advanced non-small cell lung cancer patient.
Tamura A; Inaba Higashiyama R; Yoshida T; Satozono Y; Ohe Y
Thorac Cancer; 2024 May; ():. PubMed ID: 38766698
[TBL] [Abstract][Full Text] [Related]
9. [Research Progress of BRAF Fusion in Non-small Cell Lung Cancer].
Xiao P; Zhong D
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):782-788. PubMed ID: 37989341
[TBL] [Abstract][Full Text] [Related]
10. Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.
Aparicio I; Iranzo P; Reyes R; Bote H; Saigi M; Bringas M; Bosch-Barrera J; Corral J; Aparisi F; Ruffinelli JC; Jiménez B; Lage Y; López-Castro R; Majem M; Vázquez S; Artal Á; Rodríguez-Pérez Á; Lázaro-Quintela M; Torres JMS; Reguart N; Cucurull M; Gil-Bazo I; Camps C; Nadal E; Del Barrio A; Garrido P; Dómine M; Álvarez R; Muñoz AJ; Calles A
Thromb Res; 2023 Dec; 232():133-137. PubMed ID: 37976733
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of non-small cell lung cancer patients with non-V600E
Lazar R; Fischbach C; Schott R; Somme L
Front Oncol; 2024; 14():1307882. PubMed ID: 38601760
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and cumulative analysis of clinical properties of BRAF V600E mutations in PLNTY histological samples.
Baumgartner ME; Lang SS; Tucker AM; Madsen PJ; Storm PB; Kennedy BC
Childs Nerv Syst; 2024 May; 40(5):1361-1366. PubMed ID: 38150037
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological features of adult Wilms tumor with BRAF V600E mutation].
Gan HL; Wang QF; Zhu XL; Lyu H; Wang J
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1210-1215. PubMed ID: 38058036
[No Abstract] [Full Text] [Related]
14. Clinicopathological aspects of V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) mutated non-small cell lung carcinoma in an Indian cohort: is there a difference?
Batra U; Nathany S; Sharma M; Mattoo S; Mehta A; Jose JT
Int J Mol Epidemiol Genet; 2021; 12(6):112-119. PubMed ID: 35126834
[TBL] [Abstract][Full Text] [Related]
15. Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer.
Mezquita L; Oulhen M; Aberlenc A; Deloger M; Aldea M; Honore A; Lecluse Y; Howarth K; Friboulet L; Besse B; Planchard D; Farace F
Br J Cancer; 2024 Mar; 130(4):682-693. PubMed ID: 38177660
[TBL] [Abstract][Full Text] [Related]
16. BRAF testing modalities in histiocytic disorders: Comparative analysis and proposed testing algorithm.
Acosta-Medina AA; Abeykoon JP; Go RS; Goyal G; Ravindran A; Schram SM; Rech KL
Am J Clin Pathol; 2023 Nov; 160(5):483-489. PubMed ID: 37458275
[TBL] [Abstract][Full Text] [Related]
17. BRAF
Planchard D; Sanborn RE; Negrao MV; Vaishnavi A; Smit EF
NPJ Precis Oncol; 2024 Apr; 8(1):90. PubMed ID: 38627602
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-propelled liposome circumvention and siRNA silencing reverse BRAF mutation-arised cancer resistance to trametinib.
Chen J; Fang C; Chang C; Wang K; Jin H; Xu T; Hu J; Wu W; Shen E; Zhang K
Colloids Surf B Biointerfaces; 2024 Feb; 234():113710. PubMed ID: 38113749
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Treatment Outcomes of 65 Patients With BRAF-Mutated Non-small Cell Lung Cancer.
Mu Y; Yang K; Hao X; Wang Y; Wang L; Liu Y; Lin L; Li J; Xing P
Front Oncol; 2020; 10():603. PubMed ID: 32411601
[TBL] [Abstract][Full Text] [Related]
20. Novel Resistance Mechanisms Including L1196Q, P1094H, and R1248_D1249 Insertion in Three Patients With NSCLC After ALK Tyrosine Kinase Inhibitor Treatment.
Furuta H; Araki M; Masago K; Sagae Y; Fujita S; Seto K; Shimizu J; Horio Y; Sasaki E; Hosoda W; Katayama R; Okuno Y; Hida T
J Thorac Oncol; 2021 Mar; 16(3):477-482. PubMed ID: 33166721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
